Search

everythinglearnresearchcommunity

for

Search:↓

Flutamide and finasteride reduced sex hormones in pregnant hyenas, but increased them in males.

Hair loss in women may have causes other than hormones.

High levels of male hormones in pregnant mice cause heart enlargement and poor heart function in their female babies.

The conclusion is that removing both ovaries is the best treatment for excess male hormones in postmenopausal women, with medication as another option, and managing insulin resistance is important for diagnosis and treatment.

Finasteride and spironolactone both reduce hirsutism, but finasteride lowers androgen levels more.

Antiandrogen therapies are beneficial for treating skin and hair conditions related to androgen levels.

Spironolactone improved blood vessel function and cholesterol levels in non-obese women with PCOS.

Germacrone from Curcuma aeruginosa may help treat conditions related to male hormones by blocking a specific enzyme.

Hair loss from genetics and hormones can be treated with drugs or surgery.

Diagnosing hyperandrogenism in women is complex and requires accurate testing methods and consideration of SHBG levels.

RU58841 significantly increases hair growth rate and initiates more hair cycles, but doesn't affect hair thickness, suggesting it could be a new treatment for baldness.

The document concludes that hirsutism can be managed with various treatments tailored to the individual, potentially improving quality of life.

The conclusion is that early diagnosis and a multi-system treatment approach are crucial for managing PCOS and its associated health risks.

FPHL is a common, age-related, genetic hair loss with unclear causes and limited treatment options.

Metformin helps manage diabetes, PCOS, and weight in kids but needs more research for long-term safety.

Estrogen helps prevent artery plaque by stopping monocyte capture in blood vessels.

Androgens play a key role in causing PCOS (Polycystic Ovary Syndrome).

Insulin resistance is a key factor in polycystic ovary syndrome, but genetics may also contribute.

Hair loss in women not always linked to increased oil production; other factors may be involved.

The document says that early treatment of Acne Vulgaris is important to prevent scarring and that adult onset acne is common in women, often due to hormonal imbalances.

Balding men had lower bone density, while balding women had higher hip bone density.

Testosterone raises blood pressure and changes kidney protein levels.

Latanoprost, a glaucoma drug, showed potential for promoting hair growth in bald monkeys, especially at higher doses.

Hair from balding and non-balding areas regrows similarly on mice.

Spironolactone effectively treats female pattern hair loss with few side effects.

A test for nail fungus was most accurate with PAS stain, low-dose spironolactone helped two-thirds of acne patients, metformin reduced symptoms of HIV-related fat distribution changes with some side effects, and skin examination with dermoscopy was better at detecting abnormal moles, while temporary tattoos can cause skin reactions.

PCOS starts in adolescence with hormonal issues, leading to adult health problems, and early treatment is crucial.

Spironolactone might help protect against severe lung problems in COVID-19 patients.

Most treatments for hair loss in 1997 were not effective for most people, and maintaining hair growth was difficult.

Treating PCOS is complex, involving medication like metformin and lifestyle changes, and requires attention to mental health due to high depression and anxiety rates.